{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T10:43:10Z","timestamp":1779187390059,"version":"3.51.4"},"reference-count":162,"publisher":"Elsevier","isbn-type":[{"value":"9780444642585","type":"print"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/bs.pbr.2020.11.002","type":"book-chapter","created":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T15:47:50Z","timestamp":1610639270000},"page":"341-378","source":"Crossref","is-referenced-by-count":14,"title":["Cortical influences of serotonin and glutamate on layer V pyramidal neurons"],"prefix":"10.1016","author":[{"given":"Gerard J.","family":"Marek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darryle D.","family":"Schoepp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/bs.pbr.2020.11.002_bb0010","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3109\/08039488.2012.752035","article-title":"Psychostimulants in moderate to severe affective disorder: A systematic review of randomized controlled trials","volume":"67","author":"Abbasowa","year":"2013","journal-title":"Nord. J. Psychiatry"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0015","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0893-133X(98)00046-3","article-title":"5-HT2 receptor regulation of extracellular GABA levels in the prefrontal cortex","volume":"20","author":"Abi-Saab","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0020","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00213-009-1484-9","article-title":"Modeling \u201cpsychosis\u201d in vitro by inducing disordered neuronal network activity in cortical brain slices","volume":"206","author":"Aghajanian","year":"2009","journal-title":"Psychopharmacologia"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0025","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0028-3908(97)00051-8","article-title":"Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells","volume":"36","author":"Aghajanian","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0030","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0006-8993(99)01224-X","article-title":"Serotonin, via 5-HT2A receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release","volume":"825","author":"Aghajanian","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0035","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.neuropharm.2015.11.031","article-title":"Translational neurophysiological markers for activity of the metabotropic glutamate receptor (mGluR2) modulator JNJ-40411813: Sleep EEG correlates in rodents and healthy men","volume":"103","author":"Ahnaou","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0040","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0306-4522(91)90128-B","article-title":"5-Hydroxytryptamine2 and 5-Hydroxytryptamine1A receptors mediate opposing responses on membrane excitability in rat association cortex","volume":"40","author":"Araneda","year":"1991","journal-title":"Neuroscience"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0045","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1124\/jpet.108.143370","volume":"327","author":"Ardayfio","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0050","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0014-2999(89)90178-7","article-title":"Facilitation of 8-OHDPAT-induced forepaw treading of rats by the 5-HT2 agonist DOI","volume":"161","author":"Arnt","year":"1989","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0055","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/syn.890170306","article-title":"Electrophysiological evidence for a functional interaction between 5-HT1A and 5-HT2A receptors in the rat medial prefrontal cortex: An iontophoretic study","volume":"17","author":"Ashby","year":"1994","journal-title":"Synapse"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0060","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fncir.2012.00012","article-title":"Selective serotonergic excitation of callosal projection neurons","volume":"6","author":"Avesar","year":"2012","journal-title":"Front Neural Circuits"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0065","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0006-8993(96)00155-2","article-title":"Amygdala input to medial prefrontal cortex (mPFC) in the rat: a light and electron microscope study","volume":"720","author":"Bacon","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0070","doi-asserted-by":"crossref","first-page":"E1382","DOI":"10.1073\/pnas.1525586113","article-title":"Presynaptic serotonin 2A receptors modulate thalamocortical plasticity associative learning","volume":"113","author":"Barre","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0075","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1021\/acschemneuro.6b00409","article-title":"Growing evidence for heterogeneous synaptic localization of 5-HT2A receptors","volume":"8","author":"Becamel","year":"2017","journal-title":"ACS Chem. Nerosci."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0080","doi-asserted-by":"crossref","first-page":"9870","DOI":"10.1073\/pnas.0700436104","article-title":"Mechanism of the 5-hydroxytryptamine2A receptor-mediated facilitation of synaptic activity in prefrontal cortex","volume":"104","author":"Beique","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0085","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1017\/S1461145712000168","article-title":"Induction of the plasticity-associated immediate early gene Arc by stress and hallucinogens: role of brain-derived neurotrophic factor","volume":"16","author":"Benekareddy","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0090","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1124\/mol.107.035170","article-title":"A selective positive allosteric modulator of metabotropic glutamate receptor subtype 2 blocks a hallucinogenic drug model of psychosis","volume":"72","author":"Benneyworth","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0095","doi-asserted-by":"crossref","first-page":"A246","DOI":"10.1096\/fasebj.20.4.A246","article-title":"Attenuation of DOI-induced head twitches in mGluR2 KO mice","volume":"20","author":"Benvenga","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0100","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3389\/fphar.2018.00208","article-title":"Metabotropic glutamate2 receptors play a key role in modulating head twitches induced by a serotonergic hallucinogen in mice","volume":"9","author":"Benvenga","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0105","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0306-4522(91)90151-D","article-title":"Restricted cortical termination fields of the midline and intralaminar thalamic nuclei in the rat","volume":"42","author":"Berendse","year":"1991","journal-title":"Neuroscience"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0110","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/j.1476-5381.1990.tb14138.x","article-title":"Behavioral evidence for functional interactions between 5-HT-receptor subtypes in rats and mice","volume":"101","author":"Berendsen","year":"1990","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0115","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0006-8993(88)90172-2","article-title":"Correspondence between 5-HT2 receptors and serotonergic axons in rat neocortex","volume":"453","author":"Blue","year":"1988","journal-title":"Brain Res."},{"issue":"Suppl 1 Pt A","key":"10.1016\/bs.pbr.2020.11.002_bb0120","first-page":"440A","article-title":"Electrophysiological studies on the effect of long-term 5-HT reuptake inhibition on the function of 5-HT neurons","volume":"15","author":"C","year":"1992","journal-title":"Clin. Neuropharmacol."},{"issue":"Suppl 196","key":"10.1016\/bs.pbr.2020.11.002_bb0125","first-page":"1","article-title":"Cellular localization of brain monoamines","volume":"56","author":"Carlsson","year":"1962","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0130","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0006-3223(01)01262-8","article-title":"A double-blind placebo-controlled study of antidepressant augmentation with mirtazapine","volume":"51","author":"Carpenter","year":"2002","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/bs.pbr.2020.11.002_bb0135","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1046\/j.1471-4159.2000.0751147.x","article-title":"The potent, selective mGlu2\/3 receptor agonist LY379268 increases extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid, homovanillic acid, and 5-hydroxyindole3-acetic acid in the medial prefrontal cortex of the freely moving rat","volume":"75","author":"Cartmell","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0140","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S0028-3908(01)00034-X","article-title":"Acute increases in monoamine release in the prefrontal cortex by the mGlu2\/3 agonist LY379268 are similar in profile to risperidone, not locally mediated, and can be elicited in the presence of uptake blockade","volume":"40","author":"Cartmell","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0145","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.pnpbp.2015.12.006","article-title":"5-HT2C receptors in psychiatric disorders: a review","volume":"66","author":"Chagraoui","year":"2016","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0150","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1021\/jm801354e","article-title":"Selective 5-hydroxytryptamine 2C receptor agonists derived from the lead compound tranylcypromine: Identification of drugs with antidepressant-like action","volume":"52","author":"Cho","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0155","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/0165-6147(93)90094-Z","article-title":"Adenosine receptor subtypes","volume":"14","author":"Collis","year":"1993","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0160","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/(SICI)1096-9861(19990628)409:2<187::AID-CNE2>3.0.CO;2-P","article-title":"Cellular and subcellular distribution of the serotonin 5-HT2A receptor in the central nervous system of the rat","volume":"409","author":"Cornea-Hebert","year":"1999","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0165","first-page":"1120","article-title":"Antidepressant-like behavioral effects mediated by 5-hydroxytryptamine(2C) receptors","volume":"295","author":"Cryan","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0170","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0893-133X(00)00085-3","article-title":"Modulation by estrogen-receptor directed drugs of 5-hydroxytryptamine-2A receptors in rat brain","volume":"23","author":"Cyr","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0175","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.neuron.2011.01.020","article-title":"Impulsivity, compulsivity and top-down cognitive control","volume":"69","author":"Dalley","year":"2011","journal-title":"Neuron"},{"issue":"Suppl 232","key":"10.1016\/bs.pbr.2020.11.002_bb0180","first-page":"1","article-title":"Evidence for the existence of monoamine-containing neurons in the central nervous system","volume":"62","author":"Dalstrom","year":"1964","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0185","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/0091-3057(90)90098-3","article-title":"Do functional relationships exist between 5-HT1A and 5-HT2 receptors?","volume":"36","author":"Darmani","year":"1990","journal-title":"Pharmacol. Behav. Biochem"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0190","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0006-8993(87)90861-4","article-title":"Two distinct effects of 5-hydroxytryptamine on single cortical neurons","volume":"423","author":"Davies","year":"1987","journal-title":"Brain Res."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0195","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.3390\/ijms17111953","article-title":"d-Lysergic acid diethylamide (LSD) as a model of psychosis: mechanism of action and pharmacology","volume":"17","author":"De Gregorio","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0200","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1016\/j.neuropharm.2012.01.010","article-title":"Heterocomplex formation of 5-HT(2A)-mGlu(2) and its relevance for cellular signaling cascades","volume":"62","author":"Delille","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0205","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.neuropharm.2013.02.005","article-title":"The two faces of the pharmacological interaction of mGlu2 and 5-HT2A - Relevance of receptor heterocomplexes and interaction through functional brain pathways","volume":"70","author":"Delille","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0210","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/cne.903450104","article-title":"Expression of mu opioid receptor mRNA in rat brain: an in situ hybridization study at the single cell level","volume":"345","author":"Delphs","year":"1994","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0215","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.pharmthera.2015.11.009","article-title":"New therapeutic opportunities for 5-HT2C receptor ligands in neuropsychiatric disorders","volume":"157","author":"Di Giovanni","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0220","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1096\/fj.10-163147","article-title":"A new approach to analyze cell surface protein complexes reveals specific heterodimeric metabotropic glutamate receptors","volume":"25","author":"Doumazane","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0225","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.pbb.2011.04.003","article-title":"Role of endocannabinoid and glutamatergic systems in DOI-induced head-twitch response in mice","volume":"99","author":"Egashira","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0230","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ejphar.2011.03.055","article-title":"Effect of brain-derived neurotrophic factor on activity-regulated cytoskeleton-associated protein gene expression in primary frontal cortical neurons","volume":"660","author":"El-Sayed","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0235","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0169-328X(99)00207-7","volume":"71","author":"Erdtmann-Vourliotis","year":"1999","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0240","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1124\/jpet.110.172247","article-title":"Interaction of 5-HT2A and 5-HT2C receptors in R(\u2212)-2,5-dimethoxy-4-iodoamphetamine-elicited head twitch behavior in mice","volume":"335","author":"Fantegrossi","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"6","key":"10.1016\/bs.pbr.2020.11.002_bb0245","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.19m12928","article-title":"A phase 2, randomized, double-blind, placebo-controlled study of adjunctive pimavanserin in patients with major depressive disorder and an inadequate response to therapy (CLARITY)","volume":"80","author":"Fava","year":"2019","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0250","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1124\/jpet.110.172957","volume":"336","author":"Fell","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0255","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1600-0447.2001.00148.x","article-title":"Benefits from mianserin augmentation of fluoxetine in patients with major depression non-responders to fluoxetine alone","volume":"103","author":"Ferreri","year":"2001","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0260","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0031-6997(24)01511-4","article-title":"International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors","volume":"53","author":"Fredholm","year":"2001","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0265","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev.pharmtox.45.120403.095731","article-title":"Actions of adenosine at its receptors in the CNS: Insights from knockouts and drugs","volume":"45","author":"Fredholm","year":"2005","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0270","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.cell.2011.09.055","article-title":"Decoding the signaling of a GPCR heteromeric complex reveals a unifying mechanism of action of antipsychotic drugs","volume":"147","author":"Fribourg","year":"2011","journal-title":"Cell"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0275","series-title":"The Prefrontal Cortex","author":"Fuster","year":"2015"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0280","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/BF00337069","article-title":"Evidence for the existence of monoamine neurons in the central nervous system. III. The monoamine nerve terminal","volume":"65","author":"Fuxe","year":"1965","journal-title":"Z. Zellforsch."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0285","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0893-133X(00)00136-6","article-title":"Behavioral evidence for interactions between a hallucinogenic drug and group II metabotropic glutamate receptors","volume":"23","author":"Gewirtz","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0290","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0091-3057(02)00844-4","article-title":"Modulation of DOI-induced increases in cortical BDNF expression by group II mGlu receptors","volume":"73","author":"Gewirtz","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0295","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nature06612","article-title":"Identification of a serotonin\/glutamate receptor complex implicated in psychosis","volume":"452","author":"Gonzalez-Maeso","year":"2008","journal-title":"Nature"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0300","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial","volume":"30","author":"Griffiths","year":"2016","journal-title":"J Psychopharmacol"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0305","first-page":"583","article-title":"Anatomical evidence concerning the role of the thalamus in corticocortical communication: a brief review","volume":"187","author":"Guillery","year":"1995","journal-title":"J. Anat."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0310","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/BF02244363","article-title":"Comparison of the effects of mianserin and its enantiomers and metabolites on a behavioral screen for antidepressant activity","volume":"105","author":"Hand","year":"1991","journal-title":"Psychopharmacologia"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0315","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/FBP.0000000000000014","article-title":"Ketamine, but not MK-801, produces antidepressant-like effects in rats responding on a differential-reinforcement-of-low-rate operant schedule","volume":"25","author":"Hillhouse","year":"2014","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0320","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.brainres.2016.01.024","article-title":"Early attempts to visualize cortical monoamine nerve terminals","volume":"1645","author":"Hokfelt","year":"2016","journal-title":"Brain Res."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0325","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1073\/pnas.95.2.735","article-title":"5-HT2A serotonin receptors in the primate cerebral cortex: Possible site of action of hallucinogens in pyramidal cell apical dendrites","volume":"95","author":"Jakab","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0330","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.4103\/1673-5374.191222","article-title":"Serotonin regulates brain-derived neurotrophic factor expression in select brain regions during acute psychological stress","volume":"11","author":"Jiang","year":"2016","journal-title":"Neural Regen. Res."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0335","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.pnpbp.2016.01.009","article-title":"Efficacy and safety of an adjunctive mGlu2 receptor positive allosteric modulator to a SSRI\/SNRI in anxious depression","volume":"67","author":"Kent","year":"2016","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0340","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0091-3057(02)00845-6","article-title":"Group II mGlu receptor agonists inhibit behavioral and electrophysiological effects of DOI in mice","volume":"73","author":"Klodzinska","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0345","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/cne.901720408","article-title":"Projections from the amygdaloid complex to the cerebral cortex and thalamus in the rat and cat","volume":"172","author":"Krettek","year":"1977","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0350","doi-asserted-by":"crossref","first-page":"9955","DOI":"10.1523\/JNEUROSCI.21-24-09955.2001","article-title":"The role of Kv1.2-containing potassium channels in serotonin-induced glutamate release from thalamocortical terminals in rat frontal cortex","volume":"21","author":"Lambe","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0355","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0896-6273(03)00598-1","article-title":"Hypocretin (orexin) induces calcium transients in single spines postsynaptic to identified thalamocortical boutons in prefrontal slice","volume":"40","author":"Lambe","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0360","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.neuroscience.2006.12.048","article-title":"Prefrontal cortical network activity: Opposite effects of psychedelic hallucinogens and D1\/D5 dopamine receptor activation","volume":"145","author":"Lambe","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0365","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/cercor\/10.10.974","article-title":"Serotonin induces EPSCs preferentially in layer V pyramidal neurons of the frontal cortex in the rat","volume":"10","author":"Lambe","year":"2000","journal-title":"Cereb. Cortex"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0370","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1523\/JNEUROSCI.0719-05.2005","article-title":"Hypocretin and nicotine excite the same thalamocortical synapses in prefrontal cortex: correlation with improved attention in rat","volume":"25","author":"Lambe","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0375","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1093\/schbul\/sbm088","article-title":"Schizophrenia, hypocretin (orexin), and the thalamocortical activating system","volume":"33","author":"Lambe","year":"2007","journal-title":"Schizophr. Bull."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0380","article-title":"Pharmacological and pharmacokinetic properties of JNJ-40411813, a positive allosteric modulator of the mGlu2 receptor","volume":"3","author":"Lavreysen","year":"2015","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0385","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0896-6273(00)80215-9","article-title":"Transient uptake and storage of serotonin in developing thalamic neurons","volume":"17","author":"Lebrand","year":"1996","journal-title":"Neuron"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0390","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0014-2999(90)90263-6","article-title":"Antidepressant-like effects of trazodone on a behavioral screen are mediated by trazodone, not the metabolite m-chlorophenylpiperazine","volume":"177","author":"Li","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0395","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0306-4522(80)90099-8","article-title":"The serotonin innervation of the cerebral cortex in the rat - an immunohistochemical study","volume":"5","author":"Lidov","year":"1980","journal-title":"Neuroscience"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0400","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/PL00005075","article-title":"Selective visualization of rat brain 5-HT2A receptors by autoradiography with [3H]MDL 100,907","volume":"356","author":"Lopez-Gimenez","year":"1997","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0405","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00004714-199904000-00014","article-title":"Pindolol and mianserin augment the antidepressant activity of fluoxetine in hospitalized major depressed patients, including those with treatment resistance","volume":"19","author":"Maes","year":"1999","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0410","first-page":"14307","article-title":"Manganese-enhanced magnetic resonance imaging reveals increased DOI-induced brain activity in a mouse model of schizophrenia","volume":"30","author":"Malkova","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0415","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/cne.903500307","article-title":"Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study","volume":"350","author":"Mansour","year":"1994","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0420","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0006-8993(94)90031-0","article-title":"\u03bc-Opioid receptor mRNA expression in the rat CNS: comparison to \u03bc-receptor binding","volume":"643","author":"Mansour","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0425","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.neulet.2008.04.068","article-title":"Cortical 5-hydroxytryptamine2A-receptor mediated excitatory synaptic currents in the rat following repeated daily fluoxetine administration","volume":"438","author":"Marek","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0430","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.euroneuro.2008.01.003","article-title":"Regulation of rat cortical 5-hydroxytryptamine2A-receptor mediated electrophysiological responses by repeated daily treatment with electroconvulsive shock or imipramine","volume":"18","author":"Marek","year":"2008","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0435","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.neuropharm.2009.03.005","article-title":"Activation of adenosine1 (A1) receptors suppresses head shakes induced by a serotonergic hallucinogen","volume":"56","author":"Marek","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0440","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1124\/jpet.112.191718","article-title":"Activation of adenosine1 receptors induces antidepressant-like, anti-impulsive effects on differential reinforcement of low-rate 72-s behavior in rats","volume":"341","author":"Marek","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0445","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/7854_2017_480","article-title":"Interactions of hallucinogens with the glutamatergic system: Permissive network effects mediated through cortical layer V pyramidal neurons","volume":"36","author":"Marek","year":"2018","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0450","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0306-4522(98)00043-8","article-title":"5-HT-induced EPSCs in neocortical layer V pyramidal cells: Suppression by \u03bc-opiate receptor activation","volume":"86","author":"Marek","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0455","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0014-2999(98)00945-5","article-title":"5-HT2A or \u03b11-adrenoceptor activation induces excitatory postsynaptic currents in layer V pyramidal cells of the medial prefrontal cortex","volume":"367","author":"Marek","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0460","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3389\/fphar.2018.00089","article-title":"\u03b22-Adrenergic receptor activation suppresses the rat phenethylamine hallucinogen-induced head twitch response: hallucinogen-induced excitatory post-synaptic potentials as a potential substrate","volume":"9","author":"Marek","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0465","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1124\/jpet.119.264069","article-title":"Extending the specificity of DRL 72-s behavior for screening antidepressant-like effects of glutamatergic clinically validated anxiolytic or antidepressant drugs in rats","volume":"374","author":"Marek","year":"2020","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0470","first-page":"650","article-title":"Effects of selective 5-hydroxytryptamine-2 and nonselective 5-hydroxytryptamine antagonists on the differential-reinforcement-of-low-rate 72-second schedule","volume":"244","author":"Marek","year":"1988","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0475","first-page":"60","article-title":"Evidence for involvement of 5-hydroxytryptamine1 receptors in antidepressant-like drug effects on differential-reinforcement-of-low-rate 72-second behavior","volume":"250","author":"Marek","year":"1989","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0480","first-page":"52","article-title":"Selective 5-hydroxytryptamine2 antagonists have antidepressant-like effects on differential-reinforcement-of-low-rate 72-second schedule","volume":"250","author":"Marek","year":"1989","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0485","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/BF02245475","article-title":"A comparison of trazodone and fluoxetine: implications for a serotonergic mechanism of antidepressant action","volume":"109","author":"Marek","year":"1992","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0490","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0022-3565(24)35262-0","article-title":"Physiological antagonism between 5-hydroxytryptamine2A and group II metabotropic glutamate receptors in prefrontal cortex","volume":"292","author":"Marek","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0495","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0306-4522(01)00199-3","article-title":"A major role for thalamocortical afferents in serotonergic hallucinogen receptor function in the rat neocortex","volume":"105","author":"Marek","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0500","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/sj.npp.1300057","article-title":"Synergistic action of 5-HT2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric disorders","volume":"28","author":"Marek","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0505","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1038\/sj.npp.1300762","article-title":"The selective 5-HT2A receptor antagonist M100907 enhances antidepressant-like behavioral effects of the SSRI fluoxetine","volume":"30","author":"Marek","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0510","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1124\/jpet.115.229922","article-title":"The utility of impulsive bias and altered decision making as predictors of drug efficacy and target selection: Rethinking behavioral screening for antidepressant drugs","volume":"356","author":"Marek","year":"2016","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0515","series-title":"Antidepressants\u2013Preclinical, Clinical, and Translational Aspects","first-page":"228","article-title":"Orexin 2 receptor antagnists from prefrontal cortical circuitry to rodent behavioral screens","author":"Marek","year":"2019"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0520","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0022-3565(24)37669-4","article-title":"5-HT2C receptor agonists: pharmacological characteristics and therapeutic potential","volume":"286","author":"Martin","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0525","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/736439","article-title":"The mGlu2\/3 receptor agonists LY354740 and LY379268 differentially regulate restraint-stress-induced expression of c-Fos in rat cerebral cortex","volume":"2013","author":"Menezes","year":"2013","journal-title":"Neurosci. J."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0530","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0006-8993(90)90502-3","article-title":"Localization of the mRNA for the 5-HT2 receptor by in situ hybridization histochemistry. Correlation with the distribution of receptor sites","volume":"524","author":"Mengod","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0535","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1021\/acschemneuro.5b00023","article-title":"Cartography of 5-HT1A and 5-HT2A receptor subtypes in prefrontal cortex and its projections","volume":"6","author":"Mengod","year":"2015","journal-title":"ACS Chem. Nerosci."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0540","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0306-4522(02)00580-8","article-title":"Ultrastructural localization of serotonin2A receptors in the middle layers of the rat prelimbic prefrontal cortex","volume":"116","author":"Miner","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0545","doi-asserted-by":"crossref","first-page":"15340","DOI":"10.1523\/JNEUROSCI.3289-14.2014","article-title":"Advances in understanding mechanisms of thalamic relays in cognition and behavior","volume":"34","author":"Mitchell","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0550","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0028-3908(95)00167-0","article-title":"Chronic electroconvulsive shock enhances 5-HT2 receptor-mediated head shakes but not brain C-fos induction","volume":"35","author":"Moorman","year":"1996","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0555","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.neulet.2011.01.046","article-title":"Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists","volume":"493","author":"Moreno","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0560","doi-asserted-by":"crossref","first-page":"44301","DOI":"10.1074\/jbc.M112.413161","article-title":"Identification of three residues essential for 5-hydroxtryptamine 2A-metabotropic glutamate 2 (5-HT2A-mGlu2) receptor heteromerizaiton and its psychoactive behavioral function","volume":"287","author":"Moreno","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0565","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/0306-4522(93)90241-7","article-title":"Immunocytochemical localization and description of neurons expressing serotonin2 receptors in rat brain","volume":"54","author":"Morilak","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0570","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/sj.npp.1380102","article-title":"Neurons expressing 5-HT2 receptors in the rat brain: neurochemical identification of cell types by immunocytochemistry","volume":"11","author":"Morilak","year":"1994","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0575","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.neuropharm.2014.08.009","article-title":"Evaluation of 5-HT2A and mGlu2\/3 receptors in postmortem prefrontal cortex of subjects with major depressive disorder: effect of antidepressant treatment","volume":"86","author":"Muguruza","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0580","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.neuropharm.2008.08.020","article-title":"Serotonin transporter transgenic (SERTcre) mouse line reveals developmental targets of serotonin specific reuptake inhbitors (SSRIs)","volume":"55","author":"Narboux-Neme","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0585","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.bbr.2007.11.016","article-title":"The 5-HT(2C) receptor agonist WAY-163909 decreases impulsivity in the 5-choice serial reaction time test","volume":"188","author":"Navarra","year":"2008","journal-title":"Behav. Brain Res."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0590","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1176\/appi.ajp.2009.09030312","article-title":"Atypical antipsychotic augmentation in major depressive disorders: A meta-analysis of placebo-controlled randomized trials","volume":"166","author":"Nelson","year":"2009","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0595","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1124\/pr.115.011478","article-title":"Psychedelics","volume":"68","author":"Nichols","year":"2016","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0600","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1124\/jpet.110.170506","article-title":"Effects of a positive allosteric modulatory of group II metabotropic glutamate receptors, LY487379, on cognitive flexibility and impulsive-like responding in rats","volume":"335","author":"Nikiforuk","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0605","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cell.2020.03.020","article-title":"Psychedelic Psychiatry's Brave New World","volume":"181","author":"Nutt","year":"2020","journal-title":"Cell"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0610","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.neubiorev.2005.03.018","article-title":"Antidepressant effects assessed using behavior maintained under a differential-reinforcement-of-low-rate (DRL) operant schedule","volume":"29","author":"O'Donnell","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0615","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/0306-4522(93)90485-X","article-title":"Distribution of the messenger RNA for a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat","volume":"53","author":"Ohishi","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0620","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0168-0102(97)00120-X","article-title":"Distribution of a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat and mouse: an immunohistochemical study with a monoclonal antibody","volume":"30","author":"Ohishi","year":"1998","journal-title":"Neurosci. Res."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0625","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00213-017-4545-5","article-title":"A short history of the 5-HT2C receptor from the choroid plexus to depression, obesity and addiction treatments","volume":"234","author":"Palacios","year":"2017","journal-title":"Psychopharmacol"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0630","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.neuropharm.2008.06.033","article-title":"Peripheral administration of group III mGlu receptor agonist ACPT-I exerts potential antipsychotic effects in rodents","volume":"55","author":"Palucha-Poniewiera","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0635","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.neuropharm.2003.09.017","article-title":"Glutamate receptor activation is involved in 5-HT2 agonist-induced Arc gene expression in the rat cortex","volume":"46","author":"Pei","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0640","first-page":"1","article-title":"LSD acutely impairs working memory, executive functions, and cognitive flexibility, but not risk-based decision-making","author":"Pokorny","year":"2019","journal-title":"Psychol. Med."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0645","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jad.2016.07.006","article-title":"Lisdexamfetamine dimesylate augmentation for adults with major depressive disorder and inadequate response to antidepressant monotherapy: Results from 2 phase 3, multicenter, randomized, double-blind, placebo-controlled studies","volume":"206","author":"Richards","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0650","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s00213-002-1154-7","article-title":"The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry","volume":"163","author":"Robbins","year":"2002","journal-title":"Psychopharmacologia"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0655","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1124\/jpet.106.110809","volume":"321","author":"Rorick-Kehn","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0660","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3389\/fphar.2017.00974","article-title":"Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression","volume":"8","author":"Roseman","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0665","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00213-007-0710-6","article-title":"Antidepressant-like effects of the novel, selective 5-HT2C receptor agonist WAY-163909 in rats","volume":"192","author":"Rosenweig-Lipson","year":"2007","journal-title":"Psychopharmacologia"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0670","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1177\/0269881116675512","article-title":"Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial","volume":"30","author":"Ross","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0675","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3389\/fnsys.2014.00083","article-title":"Intralaminar and medial thalamic influence on cortical synchrony, information transmission and cognition","volume":"8","author":"Saalmann","year":"2014","journal-title":"Front Sys. Neurosci"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0680","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3389\/fnana.2017.00087","article-title":"Laminar and cellular distribution of monoamine receptors in rat medial prefrontal cortex","volume":"11","author":"Santana","year":"2017","journal-title":"Front Neuroanat"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0685","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.bbr.2013.11.022","article-title":"D-serine deficiency attenuates the behavioral and cellular effects induced by the hallucinogenic 5-HT2A receptor agonist DOI","volume":"259","author":"Santini","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0690","first-page":"241","article-title":"Stimulants in the treatment of depression: A critical overview","volume":"50","author":"Satel","year":"1989","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0695","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.biopsych.2014.11.015","article-title":"Acute effects of lysergic acid diethylamide in healthy subjects","volume":"78","author":"Schmid","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0700","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0022-3565(24)29296-X","article-title":"Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system","volume":"299","author":"Schoepp","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0705","first-page":"101","article-title":"(1-(2,5-Dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine(5-HT)2A receptors: Modulation by novel 5-HT2A\/2C antagonists, D1 antagonists and 5-HT1A agonists","volume":"273","author":"Schreiber","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0710","doi-asserted-by":"crossref","first-page":"8846","DOI":"10.1523\/JNEUROSCI.20-23-08846.2000","article-title":"DOI-induced activation of the cortex: Dependence upon 5-HT2A heteroceptors on thalamocortical glutamatergic neurons","volume":"20","author":"Scruggs","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0715","series-title":"Exploring the Thalamus and Its Role in Cortical Function","author":"Sherman","year":"2005"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0720","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1111\/bph.12254","article-title":"The antipsychotic-like effects of positive allosteric modulators of metabotropic glutamate mGlu4 receptors in rodents","volume":"169","author":"Slawinska","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0725","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0306-4522(01)00170-1","article-title":"Adenosine preferentially suppresses serotonin2A receptor-enhanced excitatory postsynaptic currents in layer V neurons of the rat medial prefrontal cortex","volume":"105","author":"Stutzman","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0730","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.cub.2016.02.010","article-title":"Increased global functional connectivity correlates with LSD-induced ego dissolution","volume":"26","author":"Tagliazucchi","year":"2016","journal-title":"Curr. Biol."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0735","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1523\/JNEUROSCI.17-08-02785.1997","article-title":"5-HT2A receptor mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex","volume":"17","author":"Vaidya","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0740","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neubiorev.2015.01.014","article-title":"Limbic circuitry of the midline thalamus","volume":"54","author":"Vertes","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0745","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1126\/science.1123432","article-title":"Cortical 5-HT2A receptor signalling modulates anxiety-like behaviors in mice","volume":"313","author":"Weisstaub","year":"2006","journal-title":"Science"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0750","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00213-011-2502-2","article-title":"Opposing efficacy of group III mGlu receptor activators, LSP1-2111 and AMN082, in animal models of positive symptoms of schizophrenia","volume":"220","author":"Wieronska","year":"2012","journal-title":"Psychopharmacologia"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0755","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.bbr.2013.08.007","article-title":"The reversal of cognitive, but not negative or positive symptoms of schizophrenia by the mGlu2\/3 receptor agonist, LY379268, is 5-HT1A dependent","volume":"256","author":"Wieronska","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0760","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0022-3565(24)36840-5","article-title":"Direct injection of 5-HT2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats","volume":"282","author":"Willins","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0765","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/(SICI)1098-2396(199709)27:1<79::AID-SYN8>3.0.CO;2-A","article-title":"Serotonin 5-HT2A receptors are expressed on pyramidal cells and interneurons in the rat cortex","volume":"27","author":"Willins","year":"1997","journal-title":"Synapse"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0770","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00213-011-2441-y","article-title":"Pretreatment with the mGlu2\/3 receptor agonist LY379268 attenuates DOI-induced impulsive responding and regional c-Fos protein expression","volume":"219","author":"Wischhof","year":"2012","journal-title":"Psychopharmacologia"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0775","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.2174\/1568026619666190709101449","article-title":"Targeting the 5-HT2C receptor in biological context and the current state of 5-HT2C receptor ligand development","volume":"19","author":"Wold","year":"2019","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0780","series-title":"Effect of chronic exposure to mGlu2\/3 receptor ligands (LY354740, LY379268 or LY341495) or antipsychotic agents clozapine or haloperidol on binding to mGlu2\/3 and 5-HT2A receptors in rat prelimbic cortex","author":"Wright","year":"2003"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0785","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/cne.903510304","article-title":"Comparative localization of serotonin1A, 1C, and 2 receptor subtype mRNAs in rat brain","volume":"351","author":"Wright","year":"1995","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0790","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neuropharm.2012.01.019","article-title":"CNS distribution of metabotropic glutamate 2 and 3 receptors: Transgenic mice and [3H]LY459477 autoradiography","volume":"66","author":"Wright","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0795","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0361-9230(99)00278-6","article-title":"Cellular localization of serotonin2A (5-HT2A) receptors in rat brain","volume":"51","author":"Xu","year":"2000","journal-title":"Brain Res. Bull."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0800","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/sj.npp.1300013","article-title":"Group II metabotropic glutamate receptor modulation of DOI-induced c-fos mRNA and excitatory responses in the cerebral cortex","volume":"28","author":"Zhai","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0805","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1124\/jpet.106.107490","article-title":"Group III metabotropic glutamate receptor agonists selectively suppress excitatory synaptic currents in the rat prefrontal cortex induced by 5-hydroxytryptamine2A receptor stimulation","volume":"320","author":"Zhang","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/bs.pbr.2020.11.002_bb0810","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.pnpbp.2007.07.009","article-title":"AMPA receptor involvement in 5-hydroxytryptamine2A receptor-mediated pre-frontal cortical excitatory synaptic currents and DOI-induced head shakes","volume":"32","author":"Zhang","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/bs.pbr.2020.11.002_bb0815","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.neuropharm.2016.04.033","article-title":"Examination of the hippocampal contribution to serotonin 5-HT2A receptor-mediated facilitation of object memory in C57BL\/6J mice","volume":"109","author":"Zhang","year":"2016","journal-title":"Neuropharmacology"}],"container-title":["Progress in Brain Research","5-HT Interaction with Other Neurotransmitters: Experimental Evidence and Therapeutic Relevance - Part B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S007961232030217X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S007961232030217X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T17:08:25Z","timestamp":1738170505000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S007961232030217X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9780444642585"],"references-count":162,"URL":"https:\/\/doi.org\/10.1016\/bs.pbr.2020.11.002","relation":{},"ISSN":["0079-6123"],"issn-type":[{"value":"0079-6123","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]}}}